Arroyo BioSciences, LLC is discovering new drugs for the treatment of chronic inflammatory diseases characterized by fibrosis. This family of debilitating diseases strikes major organs and is often poorly diagnosed and treated.
View fibrotic disease types for each area of the body by brushing your mouse over each title below:
In 2015, Arroyo Biosciences LLC granted a worldwide licensed for all AB compounds to SPR Biosciences LLC. More information on development of the AB compounds, including AB22 currently under development for Idiopathic Pulmonary Fibrosis, can be found at www.sprbiosciences.com.